Mannkind stock soars over new label info for Afrezza
Earnings, Health Care & Life Science, Latest news, Technology, Tri-County Public CompaniesWestlake Village biotech company Mannkind received approval to update the prescribing information for its inhalable insulin product, Afrezza, making it easier to market to customers. The new label information clarifies starting and adjusting mealtime dosages, as well as initial and peak effects, and helps the company avoid confusing language, CEO Michael Castagna said in a Read More →
CalAmp reports revenue decline but net income up
Earnings, Latest news, Technology, Tri-County Public Companies, West Ventura CountyInformation technology company CalAmp reported on Sept. 28 a slight drop in revenue for its second quarter but a dramatic increase in net income, bringing in $12.2 million, or 34 cents per share. The company, which has operations in Oxnard, brought in $89.8 million during the quarter, down slightly from $90.5 million in the second Read More →
Museum of Ventura County replaces board with 11 new members
East Ventura County, Latest news, Nonprofits, West Ventura CountyUpdated at 10:20 a.m. Sept. 29: The Museum of Ventura County has replaced its board of directors and elected 11 new board members, it announced in a news release Sept. 28. The museum has faced financial woes and possible closure in the past few years. It streamlined its budget to $1.1 million as of May Read More →
Amgen settles with AbbVie over Humira biosimilar
East Ventura County, Health Care & Life Science, Latest news, TechnologyThousand Oaks biopharmaceutical giant Amgen announced Sept. 28 that it had reached a settlement with Chicago-based competitor AbbVie, which had sued to block Amgen’s Humira biosimilar Amjevita. The rheumatoid arthritis and inflammation treatment received U.S. Food and Drug Administration approval in September of 2016, but sales were blocked when AbbVie filed a patent infringement claim Read More →